Table 2. The nucleotides in this study.

Name	Sequences
HCP5 forward primer	5’-TGAGAGCAGGACAGGAAAA-3’
HCP5 reverse primer	5’-CCAACCAGACCCTAAGTGA-3’
miR-29b-3p forward primer	5’-AGGCTAGCACCATTTGAAATC-3’
miR-29b-3p reverse primer	5’-GAGAGGAGAGGAAGAGGGAA-3’
DNMT3A forward primer	5’-TGACACGCCAAAGGACCCTG-3’
DNMT3A reverse primer	5’-GCTCACTCCGCTTCTCCAAGT-3’
U6 forward primer	5’-CTCGCTTCGGCAGCACA-3’
U6 reverse primer	5’-GGATGGTGATGGTTTGGTAG-3’
GAPDH forward primer	5’-ATGGGGAAGGTGAAGGTCGG-3’
GAPDH reverse primer	5’-GACGGTGCCATGGAATTTGC-3’
si-HCP5	5’-GCTGGTCTCTGGACACATACTCTCGAGA GTATGTGTCCAGAGACCAGCTTTTTG-3’
miR-29b-3p mimics	5’-UAGCACCAUUUGAAAUCAGUGUU-3’
mimics NC	5’-UUCUCCGAACGUGUCACGUTT-3’
miR-29b-3p inhibitor	5’-AACACUGAUUUCAAAUGGUGCUA-3’
Inhibitor NC	5’-CAGUACUUUUGUGUAGUACAA-3’
si-DNMT3A	5’-GCCTCAGAGCTATTACCCAATCTCGAGAT TGGGTAATAGCTCTGAGGCTTTTTG-3’